Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
|
|
Prometheus Biosciences, Inc. (RXDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
SC 13G/A
| Cedars Sinai Intellectual Property Co reports a 8.4% stake in Prometheus Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| Cormorant Asset Management, LP reports a 4.5% stake in Prometheus Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 2.6% stake in Prometheus Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 2.2% stake in Prometheus Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 8.1% stake in Prometheus Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 5.1% stake in Prometheus Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| Cormorant Asset Management, LP reports a 4.8% stake in Prometheus Biosciences, Inc. |
|
|